Skip to main content
. 2020 Oct 15;111(12):4526–4539. doi: 10.1111/cas.14657

Figure 3.

Figure 3

Kaplan‐Meier plots of (A) progression‐free survival and (B) overall survival in patients treated with isatuximab at 20 mg/kg QW/Q2W in phase 2. CI, confidence interval; NR, not reached; Q2W, every 2 weeks; QW, every week